By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today filed a registration statement with the US Securities and Exchange Commission to offer senior notes to fund its acquisition of Dionex, as well as for general corporate purposes.

Details of the offering have yet to be determined, including the total amount Thermo Fisher is seeking to raise, other than the firm's intention offer three sets of senior notes due 2014, 2016, and 2021, respectively.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.